uc 3 Search Results


umuc3  (ATCC)
97
ATCC umuc3
Umuc3, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/uc+3/pm41581813-50-38-32?v=ATCC
Average 97 stars, based on 1 article reviews
umuc3 - by Bioz Stars, 2026-07
97/100 stars
  Buy from Supplier

94
ATCC human urinary bladder carcinoma cell lines
Human Urinary Bladder Carcinoma Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/uc+3/pm33176187-76-0-7?v=ATCC
Average 94 stars, based on 1 article reviews
human urinary bladder carcinoma cell lines - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

93
Bio X Cell uc3 10a6 fitc
Uc3 10a6 Fitc, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/uc+3/pmc07003741__EJI___50___97___s001-51-111-115?v=Bio+X+Cell
Average 93 stars, based on 1 article reviews
uc3 10a6 fitc - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

90
CLS Cell Lines Service GmbH shstag2 1 2
STAG2 loss augments cisplatin treatment in MIBC. A, Kaplan–Meier OS (left) and PFS (right) survival of MIBC TMA patient samples treated with cisplatin, stratified into STAG2-low (H-score 0–50, n = 12) and -high (H-score 50–300, n = 20) groups. P = 0.125 for OS, P = 0.036 for PFS; P value computed using log-rank test. B, Scanned images of crystal violet-stained HB-CLS-1, TCC-SUP, <t>T24,</t> and <t>BO2</t> colonies after 24 hours of treatment and 14 days of growth. Left: control, <t>shSTAG2-1,</t> and shSTAG-2 clonal populations treated with vehicle. Right: populations treated with 0.1 μg/mL (TCC-SUP, HB-CLS-1), 0.25 μg/mL (BO2) or 0.5 μg/mL (T24) cisplatin. Images are representative of three individual experiments. C, Surviving fraction of cells relative to untreated control for HB-CLS-1, TCC-SUP, T24, and BO2 cell lines with and without cisplatin treatment. P values determined by unpaired Student t test. Comparisons made <t>between</t> <t>untreated</t> <t>shSTAG2-1/2</t> and untreated controls, and shSTAG2-1/2+CDDP to control+CDDP. Data represented as mean + SEM. CDDP: cisplatin. Individual comparisons made using unpaired Student t test. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
Shstag2 1 2, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/uc+3/pmc09583756-195-9-10?v=CLS+Cell+Lines+Service+GmbH
Average 90 stars, based on 1 article reviews
shstag2 1 2 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

94
ATCC papoutsakis et 1988 thiolase
STAG2 loss augments cisplatin treatment in MIBC. A, Kaplan–Meier OS (left) and PFS (right) survival of MIBC TMA patient samples treated with cisplatin, stratified into STAG2-low (H-score 0–50, n = 12) and -high (H-score 50–300, n = 20) groups. P = 0.125 for OS, P = 0.036 for PFS; P value computed using log-rank test. B, Scanned images of crystal violet-stained HB-CLS-1, TCC-SUP, <t>T24,</t> and <t>BO2</t> colonies after 24 hours of treatment and 14 days of growth. Left: control, <t>shSTAG2-1,</t> and shSTAG-2 clonal populations treated with vehicle. Right: populations treated with 0.1 μg/mL (TCC-SUP, HB-CLS-1), 0.25 μg/mL (BO2) or 0.5 μg/mL (T24) cisplatin. Images are representative of three individual experiments. C, Surviving fraction of cells relative to untreated control for HB-CLS-1, TCC-SUP, T24, and BO2 cell lines with and without cisplatin treatment. P values determined by unpaired Student t test. Comparisons made <t>between</t> <t>untreated</t> <t>shSTAG2-1/2</t> and untreated controls, and shSTAG2-1/2+CDDP to control+CDDP. Data represented as mean + SEM. CDDP: cisplatin. Individual comparisons made using unpaired Student t test. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
Papoutsakis Et 1988 Thiolase, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/uc+3/lan_ethan_i__2013__redesign_of_metabolic_pathways_for_photosynthetic_production_of_n_butanol_using_cyanobacteria-1059-5-11?v=ATCC
Average 94 stars, based on 1 article reviews
papoutsakis et 1988 thiolase - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

90
Becton Dickinson anti-vγ2-pe
Phenotype of <t>Vγ2</t> + T cells in STx and ATx G8 TCR-γ/δ transgenic mice. Data show proportion of Vγ2 + cells expressing different levels of ( A ) CD45RB, ( B ) HSA, ( C ) CD44, and ( D ) CD62L in pooled LNs (▪) or spleen ( ) of STx mice, or pooled LN ( ) or spleen (□) of ATx mice. Data represent mean values ± SD for three (STx) or seven (ATx) mice that had been given BrdU for 4 d.
Anti Vγ2 Pe, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/uc+3/pmc02212127-16-19-21?v=Becton+Dickinson
Average 90 stars, based on 1 article reviews
anti-vγ2-pe - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Endress+Hauser inc uc3-e1jabccbga1g sensor
Phenotype of <t>Vγ2</t> + T cells in STx and ATx G8 TCR-γ/δ transgenic mice. Data show proportion of Vγ2 + cells expressing different levels of ( A ) CD45RB, ( B ) HSA, ( C ) CD44, and ( D ) CD62L in pooled LNs (▪) or spleen ( ) of STx mice, or pooled LN ( ) or spleen (□) of ATx mice. Data represent mean values ± SD for three (STx) or seven (ATx) mice that had been given BrdU for 4 d.
Uc3 E1jabccbga1g Sensor, supplied by Endress+Hauser inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/uc+3/us11701463-209-17-21?v=Endress%2BHauser+inc
Average 90 stars, based on 1 article reviews
uc3-e1jabccbga1g sensor - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
iCell Bioscience Inc um-uc-3
Phenotype of <t>Vγ2</t> + T cells in STx and ATx G8 TCR-γ/δ transgenic mice. Data show proportion of Vγ2 + cells expressing different levels of ( A ) CD45RB, ( B ) HSA, ( C ) CD44, and ( D ) CD62L in pooled LNs (▪) or spleen ( ) of STx mice, or pooled LN ( ) or spleen (□) of ATx mice. Data represent mean values ± SD for three (STx) or seven (ATx) mice that had been given BrdU for 4 d.
Um Uc 3, supplied by iCell Bioscience Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/uc+3/pm38403634-84-9-36?v=iCell+Bioscience+Inc
Average 90 stars, based on 1 article reviews
um-uc-3 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Schmid GmbH uc (3) sem 41c, d brown
Phenotype of <t>Vγ2</t> + T cells in STx and ATx G8 TCR-γ/δ transgenic mice. Data show proportion of Vγ2 + cells expressing different levels of ( A ) CD45RB, ( B ) HSA, ( C ) CD44, and ( D ) CD62L in pooled LNs (▪) or spleen ( ) of STx mice, or pooled LN ( ) or spleen (□) of ATx mice. Data represent mean values ± SD for three (STx) or seven (ATx) mice that had been given BrdU for 4 d.
Uc (3) Sem 41c, D Brown, supplied by Schmid GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/uc+3/10__2307_slash_2399170-261-8-2?v=Schmid+GmbH
Average 90 stars, based on 1 article reviews
uc (3) sem 41c, d brown - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Gould Instruments System Inc isometric strain gauge gould uc3
Phenotype of <t>Vγ2</t> + T cells in STx and ATx G8 TCR-γ/δ transgenic mice. Data show proportion of Vγ2 + cells expressing different levels of ( A ) CD45RB, ( B ) HSA, ( C ) CD44, and ( D ) CD62L in pooled LNs (▪) or spleen ( ) of STx mice, or pooled LN ( ) or spleen (□) of ATx mice. Data represent mean values ± SD for three (STx) or seven (ATx) mice that had been given BrdU for 4 d.
Isometric Strain Gauge Gould Uc3, supplied by Gould Instruments System Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/uc+3/pmc06487927-158-24-30?v=Gould+Instruments+System+Inc
Average 90 stars, based on 1 article reviews
isometric strain gauge gould uc3 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Schmid GmbH uc (3) sem 43b, d
Phenotype of <t>Vγ2</t> + T cells in STx and ATx G8 TCR-γ/δ transgenic mice. Data show proportion of Vγ2 + cells expressing different levels of ( A ) CD45RB, ( B ) HSA, ( C ) CD44, and ( D ) CD62L in pooled LNs (▪) or spleen ( ) of STx mice, or pooled LN ( ) or spleen (□) of ATx mice. Data represent mean values ± SD for three (STx) or seven (ATx) mice that had been given BrdU for 4 d.
Uc (3) Sem 43b, D, supplied by Schmid GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/uc+3/10__2307_slash_2399170-227-8-2?v=Schmid+GmbH
Average 90 stars, based on 1 article reviews
uc (3) sem 43b, d - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Simonsen Laboratories um-uc-3 cells
Phenotype of <t>Vγ2</t> + T cells in STx and ATx G8 TCR-γ/δ transgenic mice. Data show proportion of Vγ2 + cells expressing different levels of ( A ) CD45RB, ( B ) HSA, ( C ) CD44, and ( D ) CD62L in pooled LNs (▪) or spleen ( ) of STx mice, or pooled LN ( ) or spleen (□) of ATx mice. Data represent mean values ± SD for three (STx) or seven (ATx) mice that had been given BrdU for 4 d.
Um Uc 3 Cells, supplied by Simonsen Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/uc+3/pmc03875130-34-7-38?v=Simonsen+Laboratories
Average 90 stars, based on 1 article reviews
um-uc-3 cells - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


STAG2 loss augments cisplatin treatment in MIBC. A, Kaplan–Meier OS (left) and PFS (right) survival of MIBC TMA patient samples treated with cisplatin, stratified into STAG2-low (H-score 0–50, n = 12) and -high (H-score 50–300, n = 20) groups. P = 0.125 for OS, P = 0.036 for PFS; P value computed using log-rank test. B, Scanned images of crystal violet-stained HB-CLS-1, TCC-SUP, T24, and BO2 colonies after 24 hours of treatment and 14 days of growth. Left: control, shSTAG2-1, and shSTAG-2 clonal populations treated with vehicle. Right: populations treated with 0.1 μg/mL (TCC-SUP, HB-CLS-1), 0.25 μg/mL (BO2) or 0.5 μg/mL (T24) cisplatin. Images are representative of three individual experiments. C, Surviving fraction of cells relative to untreated control for HB-CLS-1, TCC-SUP, T24, and BO2 cell lines with and without cisplatin treatment. P values determined by unpaired Student t test. Comparisons made between untreated shSTAG2-1/2 and untreated controls, and shSTAG2-1/2+CDDP to control+CDDP. Data represented as mean + SEM. CDDP: cisplatin. Individual comparisons made using unpaired Student t test. *, P < 0.05; **, P < 0.01; ***, P < 0.001.

Journal: Cancer Research Communications

Article Title: STAG2 Expression is Associated with Adverse Survival Outcomes and Regulates Cell Phenotype in Muscle-invasive Bladder Cancer

doi: 10.1158/2767-9764.CRC-22-0155

Figure Lengend Snippet: STAG2 loss augments cisplatin treatment in MIBC. A, Kaplan–Meier OS (left) and PFS (right) survival of MIBC TMA patient samples treated with cisplatin, stratified into STAG2-low (H-score 0–50, n = 12) and -high (H-score 50–300, n = 20) groups. P = 0.125 for OS, P = 0.036 for PFS; P value computed using log-rank test. B, Scanned images of crystal violet-stained HB-CLS-1, TCC-SUP, T24, and BO2 colonies after 24 hours of treatment and 14 days of growth. Left: control, shSTAG2-1, and shSTAG-2 clonal populations treated with vehicle. Right: populations treated with 0.1 μg/mL (TCC-SUP, HB-CLS-1), 0.25 μg/mL (BO2) or 0.5 μg/mL (T24) cisplatin. Images are representative of three individual experiments. C, Surviving fraction of cells relative to untreated control for HB-CLS-1, TCC-SUP, T24, and BO2 cell lines with and without cisplatin treatment. P values determined by unpaired Student t test. Comparisons made between untreated shSTAG2-1/2 and untreated controls, and shSTAG2-1/2+CDDP to control+CDDP. Data represented as mean + SEM. CDDP: cisplatin. Individual comparisons made using unpaired Student t test. *, P < 0.05; **, P < 0.01; ***, P < 0.001.

Article Snippet: We utilized four cell lines with STAG2 KD via shSTAG2-1/2 (HB-CLS-1, TCC-SUP, T24, and BO2) in addition to UM-UC-3 cells with STAG2 overexpression.

Techniques: Staining, Control

Phenotype of Vγ2 + T cells in STx and ATx G8 TCR-γ/δ transgenic mice. Data show proportion of Vγ2 + cells expressing different levels of ( A ) CD45RB, ( B ) HSA, ( C ) CD44, and ( D ) CD62L in pooled LNs (▪) or spleen ( ) of STx mice, or pooled LN ( ) or spleen (□) of ATx mice. Data represent mean values ± SD for three (STx) or seven (ATx) mice that had been given BrdU for 4 d.

Journal: The Journal of Experimental Medicine

Article Title: Lifespan of γ/δ T Cells

doi:

Figure Lengend Snippet: Phenotype of Vγ2 + T cells in STx and ATx G8 TCR-γ/δ transgenic mice. Data show proportion of Vγ2 + cells expressing different levels of ( A ) CD45RB, ( B ) HSA, ( C ) CD44, and ( D ) CD62L in pooled LNs (▪) or spleen ( ) of STx mice, or pooled LN ( ) or spleen (□) of ATx mice. Data represent mean values ± SD for three (STx) or seven (ATx) mice that had been given BrdU for 4 d.

Article Snippet: Single cell suspensions were made from pooled LNs, thymus, or spleen and were surface stained using the following antibodies: Anti-Vγ2-PE ( PharMingen , San Diego, CA); anti-CD4-PE (Collaborative Biomedical Products Co., New Bedford, MA), pan anti–TCR-γ/δ–PE ( PharMingen ); anti-CD45RB-biotin ( PharMingen ); anti-HSA-biotin (J11d); anti-CD62L-biotin (Mel-14); and anti-CD44-biotin (IM7.8.1).

Techniques: Transgenic Assay, Expressing

Turnover of T cells in TCR-γ/δ transgenic mice. ( A ) Total number of Vγ2 + T cells in spleen plus pooled LNs of STx versus ATx G8 TCR-γ/δ transgenic mice. Mean cell numbers (± SD) were calculated based on total cell yields and percentage of Vγ2 + cells in 10 STx and 12 ATx mice. ( B ) BrdU labeling of total Vγ2 + T cells in pooled LNs in STx (▴) and ATx (▪) G8 TCR-γ/δ transgenic mice. Mice were given BrdU in their drinking water, and Vγ2 + T cells in pooled LNs were analyzed at various times. Data represent mean values ± SD for two to seven mice for each time point.

Journal: The Journal of Experimental Medicine

Article Title: Lifespan of γ/δ T Cells

doi:

Figure Lengend Snippet: Turnover of T cells in TCR-γ/δ transgenic mice. ( A ) Total number of Vγ2 + T cells in spleen plus pooled LNs of STx versus ATx G8 TCR-γ/δ transgenic mice. Mean cell numbers (± SD) were calculated based on total cell yields and percentage of Vγ2 + cells in 10 STx and 12 ATx mice. ( B ) BrdU labeling of total Vγ2 + T cells in pooled LNs in STx (▴) and ATx (▪) G8 TCR-γ/δ transgenic mice. Mice were given BrdU in their drinking water, and Vγ2 + T cells in pooled LNs were analyzed at various times. Data represent mean values ± SD for two to seven mice for each time point.

Article Snippet: Single cell suspensions were made from pooled LNs, thymus, or spleen and were surface stained using the following antibodies: Anti-Vγ2-PE ( PharMingen , San Diego, CA); anti-CD4-PE (Collaborative Biomedical Products Co., New Bedford, MA), pan anti–TCR-γ/δ–PE ( PharMingen ); anti-CD45RB-biotin ( PharMingen ); anti-HSA-biotin (J11d); anti-CD62L-biotin (Mel-14); and anti-CD44-biotin (IM7.8.1).

Techniques: Transgenic Assay, Labeling

Kinetics of BrdU labeling of Vγ2 + cells in STx versus ATx G8 TCR-γ/δ transgenic mice. Mice were given BrdU continuously in their drinking water and pooled LN cells were analyzed at the indicated time points. Data show BrdU labeling of subsets of Vγ2 + cells expressing low (lo), intermediate (int), or high (hi) levels of (from top to bottom) CD44, CD45RB, CD62L or HSA in STx ( left , closed symbols ) or ATx ( right , open symbols ) TCR-γ/δ transgenic mice. Data represent mean values ± SD of two to seven mice per point.

Journal: The Journal of Experimental Medicine

Article Title: Lifespan of γ/δ T Cells

doi:

Figure Lengend Snippet: Kinetics of BrdU labeling of Vγ2 + cells in STx versus ATx G8 TCR-γ/δ transgenic mice. Mice were given BrdU continuously in their drinking water and pooled LN cells were analyzed at the indicated time points. Data show BrdU labeling of subsets of Vγ2 + cells expressing low (lo), intermediate (int), or high (hi) levels of (from top to bottom) CD44, CD45RB, CD62L or HSA in STx ( left , closed symbols ) or ATx ( right , open symbols ) TCR-γ/δ transgenic mice. Data represent mean values ± SD of two to seven mice per point.

Article Snippet: Single cell suspensions were made from pooled LNs, thymus, or spleen and were surface stained using the following antibodies: Anti-Vγ2-PE ( PharMingen , San Diego, CA); anti-CD4-PE (Collaborative Biomedical Products Co., New Bedford, MA), pan anti–TCR-γ/δ–PE ( PharMingen ); anti-CD45RB-biotin ( PharMingen ); anti-HSA-biotin (J11d); anti-CD62L-biotin (Mel-14); and anti-CD44-biotin (IM7.8.1).

Techniques: Labeling, Transgenic Assay, Expressing

Phenotype of γ/δ recent thymic emigrants. STx ( left ) or ATx ( right ) TCR-γ/δ transgenic mice were given BrdU for 2 d. Dot plots show representative staining of Vγ2 + pooled LN cells.

Journal: The Journal of Experimental Medicine

Article Title: Lifespan of γ/δ T Cells

doi:

Figure Lengend Snippet: Phenotype of γ/δ recent thymic emigrants. STx ( left ) or ATx ( right ) TCR-γ/δ transgenic mice were given BrdU for 2 d. Dot plots show representative staining of Vγ2 + pooled LN cells.

Article Snippet: Single cell suspensions were made from pooled LNs, thymus, or spleen and were surface stained using the following antibodies: Anti-Vγ2-PE ( PharMingen , San Diego, CA); anti-CD4-PE (Collaborative Biomedical Products Co., New Bedford, MA), pan anti–TCR-γ/δ–PE ( PharMingen ); anti-CD45RB-biotin ( PharMingen ); anti-HSA-biotin (J11d); anti-CD62L-biotin (Mel-14); and anti-CD44-biotin (IM7.8.1).

Techniques: Transgenic Assay, Staining

Pulse-chase BrdU labeling of Vγ2 + T cells in STx G8 TCR-γ/δ transgenic mice. Mice were given BrdU for 14 d (▪), or given BrdU for 14 d followed by normal drinking water for 28 d ( ). The percentage of BrdU + cells in pooled LNs is shown for ( A ) total Vγ2 + T cells; ( B ) Vγ2 + T cells expressing intermediate or high levels of CD45RB; ( C ) Vγ2 + T cells expressing low or high levels of HSA; ( D ) Vγ2 + T cells expressing low, intermediate, or high levels of CD44; and ( E ) Vγ2 + T cells expressing low or high levels of CD62L. Data represent mean values ± SD for 7 (14 d BrdU) or 2 (14 d BrdU plus 28 d normal water) mice.

Journal: The Journal of Experimental Medicine

Article Title: Lifespan of γ/δ T Cells

doi:

Figure Lengend Snippet: Pulse-chase BrdU labeling of Vγ2 + T cells in STx G8 TCR-γ/δ transgenic mice. Mice were given BrdU for 14 d (▪), or given BrdU for 14 d followed by normal drinking water for 28 d ( ). The percentage of BrdU + cells in pooled LNs is shown for ( A ) total Vγ2 + T cells; ( B ) Vγ2 + T cells expressing intermediate or high levels of CD45RB; ( C ) Vγ2 + T cells expressing low or high levels of HSA; ( D ) Vγ2 + T cells expressing low, intermediate, or high levels of CD44; and ( E ) Vγ2 + T cells expressing low or high levels of CD62L. Data represent mean values ± SD for 7 (14 d BrdU) or 2 (14 d BrdU plus 28 d normal water) mice.

Article Snippet: Single cell suspensions were made from pooled LNs, thymus, or spleen and were surface stained using the following antibodies: Anti-Vγ2-PE ( PharMingen , San Diego, CA); anti-CD4-PE (Collaborative Biomedical Products Co., New Bedford, MA), pan anti–TCR-γ/δ–PE ( PharMingen ); anti-CD45RB-biotin ( PharMingen ); anti-HSA-biotin (J11d); anti-CD62L-biotin (Mel-14); and anti-CD44-biotin (IM7.8.1).

Techniques: Pulse Chase, Labeling, Transgenic Assay, Expressing

Turnover of Vγ2 + thymocytes in G8 TCR-γ/δ transgenic mice. STx TCR-γ/δ transgenic mice were given BrdU for 2 (▪) or 21 ( ) d and Vγ2 + thymocytes were analyzed. ( A ) Total Vγ2 + thymocytes. ( B ) Vγ2 + CD45RB thymocyte subsets. ( C ) Vγ2 + HSA thymocyte subsets. ( D ) Vγ2 + CD44 thymocyte subsets. ( E ) Vγ2 + CD62L thymocyte subsets. Data represent mean values ± SD for two to three mice per point.

Journal: The Journal of Experimental Medicine

Article Title: Lifespan of γ/δ T Cells

doi:

Figure Lengend Snippet: Turnover of Vγ2 + thymocytes in G8 TCR-γ/δ transgenic mice. STx TCR-γ/δ transgenic mice were given BrdU for 2 (▪) or 21 ( ) d and Vγ2 + thymocytes were analyzed. ( A ) Total Vγ2 + thymocytes. ( B ) Vγ2 + CD45RB thymocyte subsets. ( C ) Vγ2 + HSA thymocyte subsets. ( D ) Vγ2 + CD44 thymocyte subsets. ( E ) Vγ2 + CD62L thymocyte subsets. Data represent mean values ± SD for two to three mice per point.

Article Snippet: Single cell suspensions were made from pooled LNs, thymus, or spleen and were surface stained using the following antibodies: Anti-Vγ2-PE ( PharMingen , San Diego, CA); anti-CD4-PE (Collaborative Biomedical Products Co., New Bedford, MA), pan anti–TCR-γ/δ–PE ( PharMingen ); anti-CD45RB-biotin ( PharMingen ); anti-HSA-biotin (J11d); anti-CD62L-biotin (Mel-14); and anti-CD44-biotin (IM7.8.1).

Techniques: Transgenic Assay

Phenotype of γ/δ cells activated in vivo. Vγ2 + T cells were purified from G8 TCR-γ/δ transgenic mice and injected into either β 2 m − ( upper ) or B6 ( lower ) mice; recipients were treated with anti–NK-1.1 antibody and irradiated before adoptive transfer (see Materials and Methods). After injection of Vγ2 + cells, recipients were given BrdU for 4 d. Dot plots show staining of spleen cells from representative mice.

Journal: The Journal of Experimental Medicine

Article Title: Lifespan of γ/δ T Cells

doi:

Figure Lengend Snippet: Phenotype of γ/δ cells activated in vivo. Vγ2 + T cells were purified from G8 TCR-γ/δ transgenic mice and injected into either β 2 m − ( upper ) or B6 ( lower ) mice; recipients were treated with anti–NK-1.1 antibody and irradiated before adoptive transfer (see Materials and Methods). After injection of Vγ2 + cells, recipients were given BrdU for 4 d. Dot plots show staining of spleen cells from representative mice.

Article Snippet: Single cell suspensions were made from pooled LNs, thymus, or spleen and were surface stained using the following antibodies: Anti-Vγ2-PE ( PharMingen , San Diego, CA); anti-CD4-PE (Collaborative Biomedical Products Co., New Bedford, MA), pan anti–TCR-γ/δ–PE ( PharMingen ); anti-CD45RB-biotin ( PharMingen ); anti-HSA-biotin (J11d); anti-CD62L-biotin (Mel-14); and anti-CD44-biotin (IM7.8.1).

Techniques: In Vivo, Purification, Transgenic Assay, Injection, Irradiation, Adoptive Transfer Assay, Staining

T cell turnover and phenotype in B6 mice. ( A ) Percentage of Vγ2 + T cells expressing low, intermediate, or high levels of CD44 in STx and ATx mice. ( B ) Proportion of Vγ2 + and CD4 + cells expressing low, intermediate, or high levels of CD44 in ATx mice. ( C ) BrdU labeling of total, CD44 lo , CD44 int and CD44 hi Vγ2 + T cells in STx and ATx B6 mice given BrdU for 7 d. ( D ) Kinetics of BrdU labeling of total Vγ2 + T cells in ATx mice. ( E ) Comparison of BrdU labeling of Vγ2 + T cells versus total TCR-γ/δ + T cells in ATx mice given BrdU for 14 d. ( F ) BrdU labeling of Vγ2 + and CD4 + T cells expressing different levels of CD44 in ATx mice given BrdU for 21 d. Data shown are for pooled LN cells and represent mean values ± SD for two to three mice per point.

Journal: The Journal of Experimental Medicine

Article Title: Lifespan of γ/δ T Cells

doi:

Figure Lengend Snippet: T cell turnover and phenotype in B6 mice. ( A ) Percentage of Vγ2 + T cells expressing low, intermediate, or high levels of CD44 in STx and ATx mice. ( B ) Proportion of Vγ2 + and CD4 + cells expressing low, intermediate, or high levels of CD44 in ATx mice. ( C ) BrdU labeling of total, CD44 lo , CD44 int and CD44 hi Vγ2 + T cells in STx and ATx B6 mice given BrdU for 7 d. ( D ) Kinetics of BrdU labeling of total Vγ2 + T cells in ATx mice. ( E ) Comparison of BrdU labeling of Vγ2 + T cells versus total TCR-γ/δ + T cells in ATx mice given BrdU for 14 d. ( F ) BrdU labeling of Vγ2 + and CD4 + T cells expressing different levels of CD44 in ATx mice given BrdU for 21 d. Data shown are for pooled LN cells and represent mean values ± SD for two to three mice per point.

Article Snippet: Single cell suspensions were made from pooled LNs, thymus, or spleen and were surface stained using the following antibodies: Anti-Vγ2-PE ( PharMingen , San Diego, CA); anti-CD4-PE (Collaborative Biomedical Products Co., New Bedford, MA), pan anti–TCR-γ/δ–PE ( PharMingen ); anti-CD45RB-biotin ( PharMingen ); anti-HSA-biotin (J11d); anti-CD62L-biotin (Mel-14); and anti-CD44-biotin (IM7.8.1).

Techniques: Expressing, Labeling

Phenotype of Vγ2 + RTEs in B6 mice. STx ( left ) or ATx ( right ) B6 mice were given BrdU for 4 d ( upper ) or 7 d ( lower ). Dot plots show representative staining of Vγ2 + pooled LN cells. The percentage of cells falling within the boxed areas is indicated.

Journal: The Journal of Experimental Medicine

Article Title: Lifespan of γ/δ T Cells

doi:

Figure Lengend Snippet: Phenotype of Vγ2 + RTEs in B6 mice. STx ( left ) or ATx ( right ) B6 mice were given BrdU for 4 d ( upper ) or 7 d ( lower ). Dot plots show representative staining of Vγ2 + pooled LN cells. The percentage of cells falling within the boxed areas is indicated.

Article Snippet: Single cell suspensions were made from pooled LNs, thymus, or spleen and were surface stained using the following antibodies: Anti-Vγ2-PE ( PharMingen , San Diego, CA); anti-CD4-PE (Collaborative Biomedical Products Co., New Bedford, MA), pan anti–TCR-γ/δ–PE ( PharMingen ); anti-CD45RB-biotin ( PharMingen ); anti-HSA-biotin (J11d); anti-CD62L-biotin (Mel-14); and anti-CD44-biotin (IM7.8.1).

Techniques: Staining